Randomized, double-blind, placebo-controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients

Phase 2

Completed

• Conditions: atex allergy; Latex allergy; Inflammatory and Immune System - Allergies

• Registration Number: ACTRN12611000543987
• Lead Sponsor: Allergy Service. Hospital Santiago Apostol

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-05-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Inclusion criteria comprised a clinical history of natural rubber latex allergy (documenting the usual symptoms of urticaria, angioedema, rhinitis, conjunctivitis, asthma or anaphylaxis) or a positive response to the gloves use test and/or conjunctival test plus positive prick test to NRL (wheal greater than or equal to 3x3 mm).

Exclusion Criteria

Exclusion criteria consisted of the usual contraindications for the use of immunotherapy and the presence of severe systemic or psychiatric diseases, chronic urticaria or dermographism.

Study & Design

• Study Type: Interventional
• Study Design: Not specified